The first new quarterly report identifies adverse drug effects that are under FDA investigation.
WebMD Health News

continue reading.....

Individuals living in Vancouver’s Downtown Eastside will benefit from two new treatment services thanks to an investment by the Government of Canada. The Honourable Tony Clement, Minister of Health, and the Honourable George Abbott, B.C. Minister of Health Services, today announced an investment of $10 million for two new treatment initiatives aimed at helping people with complex mental health issues and addiction problems to full recovery.

continue reading.....

In response to the Pharmacy White Paper related consultation on legislative changes published on 27 August, the NPA has called for new money to be made available for future pharmacy services and for a clear timetable to be put in place for a more ordered entry of businesses into the pharmacy market. John Turk, NPA Chief Executive said: “The consultation heralds further reforms of entry into the pharmacy market.

continue reading.....

Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) safety announcement regarding opportunistic fungal infections in patients treated with Tumor Necrosis Factor (TNF) blockers [marketed as Remicade® (infliximab), Enbrel® (etanercept), Humira® (adalimumab) and Cimzia® (certolizumab pegol)].

continue reading.....

The NPA is one of five bodies representing community pharmacy businesses that have submitted a joint response to the second consultation carried out by DEFRA on the Handling, Transfer and Transport of Waste. The consultation seeks views on the measures needed to reduce the incidence of fly-tipping and inappropriate disposal of waste.

continue reading.....

There may be a very good reason why coffee and cigarettes often seem to go hand in hand. A Kansas State University psychology professor’s research suggests that nicotine’s power may be in how it enhances other experiences. For a smoker who enjoys drinking coffee, the nicotine may make a cup of joe even better. And that may explain why smoking is so hard to quit.

continue reading.....

The U.S. Pharmacopeial (USP) Convention’s 2008 Annual Scientific Meeting (ASM) will be held in Kansas City, Mo., September 24 to 26. The meeting is an opportunity to interact with the USP experts responsible for establishing internationally recognized standards for prescription and over-the-counter medicines, food ingredients and dietary supplements. The focus will be on Quality of Manufactured Medicines, Food Ingredients and Dietary Supplements.

continue reading.....

Research and Markets has announced the addition of the “Biopharmaceuticals in the US and European Markets” report to their offering.

continue reading.....

First year college students believe that occasional nonmedical use of prescription pain killers and stimulants is less risky than cocaine, but more risky than marijuana or consuming five or more alcoholic beverages every weekend, according to a new study published in the September issue of Prevention Science, the peer-reviewed journal of the Society for Prevention Research.

continue reading.....

Celator Pharmaceuticals announced that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to CPX-351 (Cytarabine:Daunorubicin) Liposome Injection for the treatment of Acute Myeloid Leukemia (AML). Celator is currently preparing to conduct two randomized Phase 2 studies with CPX-351. The first Phase 2 study, in newly diagnosed, elderly patients with AML, is expected to start enrolling patients before the end of 2008.

continue reading.....